Target intelligence / Profile preview

Bridging integrator 2 pseudogene 2 (BIN2P2)

Target: BIN2P2
Molecular classification: Other (Pseudogene)

Overview

BIN2P2 is a pseudogene named for its sequence similarity to the bridging integrator 2 (BIN2) gene. Pseudogenes such as BIN2P2 do not code for proteins and are generally not considered functional therapeutic targets. While some pseudogenes are transcribed and can regulate their parental gene or participate in noncoding regulatory networks, there is no specific literature supporting a defined biological function or disease role for BIN2P2[2][3]. Most pseudogenes are considered nonfunctional genomic elements, though the field recognizes that in some cases, pseudogenes can have regulatory impacts on gene expression in cancer or other contexts[1][2][3].

Other names: BIN2P2

Biological functions

Possible regulation of parental gene expression via RNA-based mechanisms (e.g., acting as a miRNA decoy or generating siRNAs) as proposed for some pseudogenes in general, but no published evidence for BIN2P2 specifically[2][3].

Disease associations

No direct evidence of disease involvement for BIN2P2; however, some pseudogenes have been implicated in cancer and other diseases through regulatory RNA mechanisms, but these findings are pseudogene-specific and not known for BIN2P2[1][3].

Beyond the preview

Go deeper on Bridging integrator 2 pseudogene 2 (BIN2P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bridging integrator 2 pseudogene 2 (BIN2P2).

Explore the full profile